Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
Petra Hoever(Actelion (Switzerland)), Jasper Dingemanse(Actelion (Switzerland)), Bernd Saletu(Medical University of Vienna), Irshaad Ebrahim(London Studio Centre), Birgit Högl(Innsbruck Medical University), S. Van Den Berg, Georg Dorffner(Siesta Group (Austria)), Thomas Penzel(Charité - Universitätsmedizin Berlin), Markku Partinen(University of Helsinki), Göran Hajak(Sexual Health Clinic), Heidi Danker‐Hopfe(Charité - Universitätsmedizin Berlin), Claudio L. Bassetti(Swisscom (Switzerland)), Yüksel Peker(University of Gothenburg), Heike Beneš(Siesta Group (Austria)), H Bengtsson(Uppsala University Hospital), Giora Pillar(Technion – Israel Institute of Technology), Edith Holsboer‐Trachsler(University of Basel), Olli Polo(Tampere University Hospital), M.J. Barbanoj(Hospital de Sant Pau), U-M Hemmeter(Universitätsklinikum Gießen und Marburg), Dieter Kunz(Charité - Universitätsmedizin Berlin), J. Zeitlhofer(Medical University of Vienna), Eleonora Chiossi(Newron Pharmaceuticals (Italy))
Cited by 126
Related Papers
European guideline for the diagnosis and treatment of insomnia
|Journal of Sleep Research|2017|2k
Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up
|American Journal of Respiratory and Critical Care Medicine|2002|787
Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial
|American Journal of Respiratory and Critical Care Medicine|2016|730
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
|Journal of Sleep Research|2023|703
An independent association between obstructive sleep apnoea and coronary artery disease
|European Respiratory Journal|1999|480